{"entity":{"id":"nct07355231","kind":"trial","name":"Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI","aka":["GuidedRT"],"tldr":"A phase 1/2 trial in lung cancer, run by Xemed LLC, not yet recruiting.","summary":"Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI is a phase 1/2, interventional study registered as NCT07355231 by Xemed LLC, with a registry enrolment figure of 10 participants, started 2027-03-01 and due to reach its primary completion in 2028-02-29. Interventions recorded: Hyperpolarized xenon MRI. Conditions listed: Carcinoma, Non-Small-Cell Lung. Primary outcome: Changes in DLCO at 6-month post RT treatment.. Lung eligibility wording from the registry: \"* Patients over 18 years with a diagnosis of non-small lung cancer and planned for a definitive course of radiation therapy\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07355231","url":"https://clinicaltrials.gov/study/NCT07355231"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":["imrt-igrt"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07355231","phase":"1/2","setting":"Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI","sponsor":"Xemed LLC","enrolled":10,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07355231/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"technology":[{"id":"imrt-igrt","kind":"technology","name":"IMRT / IGRT (modern external beam)","route":"/technologies/imrt-igrt/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}